Section 6 of 6
References
165 sources
- Abida et al. (2019) (opens in a new tab)
- Agarwal et al. (2023) (opens in a new tab)
- Agarwal et al. (2025) (opens in a new tab)
- Akeega prescribing information (2025) (opens in a new tab)
- Alumkal and Ellis (2026) (opens in a new tab)
- American Cancer Society (2026) (opens in a new tab)
- American Cancer Society signs and symptoms (2026) (opens in a new tab)
- Annala et al. (2021) (opens in a new tab)
- Antonarakis et al. (2014) (opens in a new tab)
- Antonarakis et al. (2020) (opens in a new tab)
- Appukkuttan et al. (2021) (opens in a new tab)
- Attard et al. (2018) (opens in a new tab)
- AUA (2026) (opens in a new tab)
- Beltran et al. (2016) (opens in a new tab)
- Bosch et al. (2026) (opens in a new tab)
- California Department of Health Care Access and Information Prescription Drug Wholesale Acquisition Cost Increases (2026) (opens in a new tab)
- Caram et al. (2020) (opens in a new tab)
- Castro et al. (2025) (opens in a new tab)
- Castro et al. (2026) (opens in a new tab)
- Clarke et al. (2022) (opens in a new tab)
- ClinicalTrials.gov NCT03480646 (opens in a new tab)
- ClinicalTrials.gov NCT03480646 results (opens in a new tab)
- ClinicalTrials.gov NCT04179864 (opens in a new tab)
- ClinicalTrials.gov NCT04179864 results (opens in a new tab)
- ClinicalTrials.gov NCT05413421 (opens in a new tab)
- ClinicalTrials.gov NCT06551324 (opens in a new tab)
- ClinicalTrials.gov NCT07028853 (opens in a new tab)
- ClinicalTrials.gov NCT07723248 (opens in a new tab)
- CMS Enhancing Oncology Model (opens in a new tab)
- CMS Medicare Part B Payment Limit File (2026) (opens in a new tab)
- CMS negotiated prices fact sheet (2025) (opens in a new tab)
- CMS OPPS Addendum B (2026) (opens in a new tab)
- Corn et al. (2019) (opens in a new tab)
- Daemen et al. (2021) (opens in a new tab)
- Daemen et al. (2025) (opens in a new tab)
- de Bono et al. (2010) (opens in a new tab)
- de Bono et al. (2018) (opens in a new tab)
- de Bono et al. (2020) (opens in a new tab)
- de Feria Cardet et al. (2021) (opens in a new tab)
- de Wit et al. (2019) (opens in a new tab)
- EAU (2026) (opens in a new tab)
- eCQI Resource Center CMS645v9 (2026) (opens in a new tab)
- eCQI Resource Center CMS645v9 specification (2026) (opens in a new tab)
- Erleada prescribing information (2026) (opens in a new tab)
- FDA Tazverik safety alert (2026) (opens in a new tab)
- Fendler et al. (2023) (opens in a new tab)
- Fizazi et al. (2011) (opens in a new tab)
- Fizazi et al. (2020) (opens in a new tab)
- Fizazi et al. (2023a) (opens in a new tab)
- Fizazi et al. (2023b) (opens in a new tab)
- Fizazi et al. (2025) (opens in a new tab)
- Fizazi et al. (2026) (opens in a new tab)
- Flannery et al. (2026) (opens in a new tab)
- Freedland et al. (2023) (opens in a new tab)
- Freedland et al. (2024) (opens in a new tab)
- Friedman (2024) (opens in a new tab)
- Friedman et al. (2026) (opens in a new tab)
- Gandaglia et al. (2014) (opens in a new tab)
- George et al. (2026) (opens in a new tab)
- Gharzai et al. (2023) (opens in a new tab)
- Giri et al. (2025) (opens in a new tab)
- Gogebakan et al. (2026) (opens in a new tab)
- Hagiwara et al. (2013) (opens in a new tab)
- Halabi et al. (2016) (opens in a new tab)
- Hofman et al. (2021) (opens in a new tab)
- Hofman et al. (2024) (opens in a new tab)
- Hussain et al. (2020) (opens in a new tab)
- Jain et al. (2025) (opens in a new tab)
- Jevtana prescribing information (2023) (opens in a new tab)
- Joyce et al. (2023) (opens in a new tab)
- Joyce et al. (2024) (opens in a new tab)
- Kantoff et al. (2010) (opens in a new tab)
- Kaye et al. (2023) (opens in a new tab)
- Kaye et al. (2024a) (opens in a new tab)
- Kaye et al. (2024b) (opens in a new tab)
- Keytruda prescribing information (2026) (opens in a new tab)
- Khalaf et al. (2019) (opens in a new tab)
- Kirby et al. (2011) (opens in a new tab)
- Ku et al. (2017) (opens in a new tab)
- Kunst et al. (2025) (opens in a new tab)
- Kuppen et al. (2020) (opens in a new tab)
- Kwan et al. (2025) (opens in a new tab)
- Lloyd et al. (2015) (opens in a new tab)
- Lynparza prescribing information (2025) (opens in a new tab)
- Mahmud et al. (2026) (opens in a new tab)
- Mateo et al. (2026) (opens in a new tab)
- Matsubara et al. (2025) (opens in a new tab)
- Matsubara et al. (2026) (opens in a new tab)
- McDougall et al. (2016) (opens in a new tab)
- McKay et al. (2026) (opens in a new tab)
- Morgans et al. (2022) (opens in a new tab)
- Morgans et al. (2024) (opens in a new tab)
- Morris et al. (2015) (opens in a new tab)
- Morris et al. (2024a) (opens in a new tab)
- Morris et al. (2024b) (opens in a new tab)
- Narayan et al. (2024) (opens in a new tab)
- National Cancer Institute Prostate Cancer Treatment PDQ (opens in a new tab)
- National Cancer Institute SEER Cancer Stat Facts (opens in a new tab)
- National Cancer Institute Thesaurus (opens in a new tab)
- NCCN (2026) (opens in a new tab)
- Nubeqa prescribing information (2026) (opens in a new tab)
- ORIC Pharmaceuticals (2020) (opens in a new tab)
- ORIC Pharmaceuticals AACR preclinical data release (2026) (opens in a new tab)
- ORIC Pharmaceuticals dose exploration completion release (2025) (opens in a new tab)
- ORIC Pharmaceuticals early combination data release (2025) (opens in a new tab)
- ORIC Pharmaceuticals ESMO preclinical and translational data release (2026) (opens in a new tab)
- ORIC Pharmaceuticals expanded access policy (opens in a new tab)
- ORIC Pharmaceuticals first quarter results (2026) (opens in a new tab)
- ORIC Pharmaceuticals Form 10-K (2026) (opens in a new tab)
- ORIC Pharmaceuticals Form 10-Q (2026) (opens in a new tab)
- ORIC Pharmaceuticals Himalayas-1 initiation release (2026) (opens in a new tab)
- ORIC Pharmaceuticals initial phase 1b data release (2024) (opens in a new tab)
- ORIC Pharmaceuticals January presentation (2025) (opens in a new tab)
- ORIC Pharmaceuticals November presentation (2025) (opens in a new tab)
- ORIC Pharmaceuticals preliminary phase 1b data release (2025) (opens in a new tab)
- ORIC Pharmaceuticals presentation (2026) (opens in a new tab)
- ORIC Pharmaceuticals RP3D selection release (2026) (opens in a new tab)
- ORIC Pharmaceuticals second quarter results (2026) (opens in a new tab)
- Oster et al. (2013) (opens in a new tab)
- Pankov et al. (2026) (opens in a new tab)
- Parekh et al. (2026) (opens in a new tab)
- Parker et al. (2013) (opens in a new tab)
- Pluvicto prescribing information (2026) (opens in a new tab)
- Provenge prescribing information (opens in a new tab)
- Rao et al. (2020) (opens in a new tab)
- Rathkopf et al. (2018) (opens in a new tab)
- Raval et al. (2025) (opens in a new tab)
- Raval et al. (2026) (opens in a new tab)
- Robinson et al. (2015) (opens in a new tab)
- Rubraca prescribing information (2025) (opens in a new tab)
- Saad et al. (2002) (opens in a new tab)
- Sanyal and Rendon (2026) (opens in a new tab)
- Sartor et al. (2021) (opens in a new tab)
- Saylor et al. (2020) (opens in a new tab)
- Scher et al. (2015) (opens in a new tab)
- Scher et al. (2016) (opens in a new tab)
- Schweizer et al. (2024) (opens in a new tab)
- Schweizer et al. (2025) (opens in a new tab)
- Shevrin et al. (2026) (opens in a new tab)
- Shore et al. (2021) (opens in a new tab)
- Shore et al. (2026a) (opens in a new tab)
- Shore et al. (2026b) (opens in a new tab)
- Siegel et al. (2026) (opens in a new tab)
- Su et al. (2020) (opens in a new tab)
- Swami et al. (2023) (opens in a new tab)
- Swami et al. (2026) (opens in a new tab)
- Talzenna prescribing information (2026) (opens in a new tab)
- Tannock et al. (2004) (opens in a new tab)
- Taxotere prescribing information (2023) (opens in a new tab)
- Tazverik prescribing information (2024) (opens in a new tab)
- Teppala et al. (2024a) (opens in a new tab)
- Teppala et al. (2024b) (opens in a new tab)
- von Amsberg et al. (2026) (opens in a new tab)
- Watson et al. (2015) (opens in a new tab)
- WHO Drug Information Proposed INN List 133 (2025) (opens in a new tab)
- WHO Drug Information Recommended INN List 95 (2026) (opens in a new tab)
- Xgeva prescribing information (2026) (opens in a new tab)
- Xofigo prescribing information (2019) (opens in a new tab)
- Xtandi prescribing information (2026) (opens in a new tab)
- Xu et al. (2012) (opens in a new tab)
- Yee et al. (2024) (opens in a new tab)
- Yu et al. (2025) (opens in a new tab)
- Yuen et al. (2025) (opens in a new tab)
- Zometa prescribing information (2018) (opens in a new tab)
- Zytiga prescribing information (2021) (opens in a new tab)